Result
Feb 2, 2024 → Jul 27, 2026 · 2y 5mo
Today's value
$1,346.38+34.64%
Initial investment
$1,000
Profit
$346.38
Annual return (CAGR)
+12.73%
Historical return extremes for Alto Neuroscience (ANRO) from 2024 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +1,459% | $1.80 | $28.07 | $15,594.44 | ||
| Max drawdownMore info about Max drawdown | -91.74% | $21.80 | $1.80 | $82.57 | ||
| Return since IPOMore info about Return since IPO | +34.64% | $20.70 | $27.87 | $1,346.38 |
- Max profitMore info about Max profit+1,459%$15,594.44
- Max drawdownMore info about Max drawdown-91.74%$82.57
- Return since IPOMore info about Return since IPO+34.64%$1,346.38
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in Alto Neuroscience (ANRO). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.